GO:0170007 endoplasmic reticulum-lipid droplet tether activity

GO:0170007, endoplasmic reticulum-lipid droplet tether activity, is a Gene Ontology molecular_function term describing the binding activity of a molecule that brings a lipid droplet into close apposition with the endoplasmic reticulum membrane through membrane lipid binding, thereby establishing a membrane contact site that mediates exchange and communication. Lipid droplets are ubiquitous intracellular organelles that store neutral lipids, and their functional interplay with the endoplasmic reticulum is now recognized as a fundamental axis of cellular lipid management. The molecular tethers that physically connect these two compartments are therefore of intense research interest, because they define where and when inter-organelle lipid transfer can occur. The term is defined at the level of binding activity rather than at the level of a whole organelle or a whole pathway, which makes it directly amenable to genetic and biochemical interrogation. A protein annotated with GO:0170007 is expected to localize to ER-lipid droplet junctions and to be required for maintaining normal lipid droplet numbers, size, and lipid composition. The prototypical example is MOSPD2, which was shown to be an endoplasmic reticulum-lipid droplet tether functioning in lipid droplet homeostasis. For researchers, GO:0170007 provides a precise vocabulary for describing the molecular event that underlies ER-lipid droplet communication, and it links mechanistic cell biology to disease-relevant processes such as lipid storage disorders, metabolic stress, and cancer cell metabolism. Because the term is defined by a binding function, it can be tested experimentally by perturbing candidate tether proteins and measuring contact site formation and lipid droplet phenotypes.

In plain terms, GO:0170007 describes the molecular glue-like binding activity that holds a lipid droplet next to the endoplasmic reticulum membrane. According to the QuickGO definition, it is the binding activity of a molecule that brings together a lipid droplet with an endoplasmic reticulum membrane, via membrane lipid binding, to establish membrane contact sites and mediate exchange and communication. This is a molecular_function term: it captures the binding event itself, not the organelle, not the whole pathway, and not a downstream metabolic outcome. A protein that carries this activity must be able to associate with both the lipid droplet surface and the ER membrane, typically through lipid-binding domains, and its presence at the junction is what permits ER-lipid droplet exchange and communication.

GO:0170007 matters because it defines the molecular event that allows the endoplasmic reticulum and lipid droplets to communicate, and this communication is central to cellular lipid storage, mobilization, and membrane lipid flux. Without tethers that carry this activity, lipid droplets cannot be properly coupled to the ER, and lipid droplet homeostasis is perturbed. Because lipid droplets are involved in energy storage, membrane biogenesis, and stress responses, the binding activity described by GO:0170007 sits at the intersection of basic organelle biology and clinically relevant metabolic and oncogenic processes. Studying this term therefore helps researchers move from descriptive observations of contact sites to mechanistic, gene-level experiments.

The table below lists genes and proteins that are directly relevant to GO:0170007, with MOSPD2 as the experimentally characterized ER-lipid droplet tether.

GO:0170007 describes a binding activity that establishes ER-lipid droplet contact sites, and as such it is expected to be regulated at the level of tether protein abundance, localization, and lipid-binding competence. MOSPD2 is the experimentally defined ER-lipid droplet tether, and its function in lipid droplet homeostasis implies that the activity is responsive to cellular lipid status. Because the definition emphasizes membrane lipid binding, changes in the lipid composition of the ER or lipid droplet surface are likely to influence the efficiency of tethering. Researchers can therefore probe regulation by manipulating lipid metabolic enzymes and measuring contact site formation and lipid droplet phenotypes.

Because GO:0170007 supports lipid droplet homeostasis, defects in ER-lipid droplet tethering are mechanistically linked to disturbances in cellular lipid storage. MOSPD2 functions in lipid droplet homeostasis, and its perturbation alters lipid droplet properties, which is the kind of cellular phenotype observed in lipid storage disorders. Studying this term therefore provides a molecular framework for understanding how impaired ER-lipid droplet communication contributes to metabolic disease biology.

Lipid droplets are prominent in many cancer cells, where they support metabolic stress responses and membrane synthesis. The ER-lipid droplet tethering activity defined by GO:0170007 is part of the machinery that maintains lipid droplet homeostasis, so its perturbation could influence how cancer cells manage lipid stores. MOSPD2 provides a concrete target for testing this hypothesis in cancer cell models.

GO:0170007 is defined by the establishment of membrane contact sites between the ER and lipid droplets. Loss of such tethers disrupts exchange and communication between these organelles, which is a general mechanism of organelle contact site dysfunction. MOSPD2 is an example of a protein whose loss affects lipid droplet homeostasis, linking contact site biology to cellular dysfunction.

Fluorescence imaging of ER and lipid droplet markers allows direct visualization of the contact sites established by the activity described in GO:0170007. Tagged MOSPD2 can be used to mark ER-lipid droplet junctions and to quantify contact site abundance in wild-type and perturbed cells. This approach is the most direct way to test whether a candidate protein carries ER-lipid droplet tethering activity.

Because MOSPD2 functions in lipid droplet homeostasis, measuring lipid droplet number, size, and lipid composition is a key readout for GO:0170007-related experiments. Lipid droplet phenotyping can be performed with neutral lipid stains and quantitative image analysis. Comparing wild-type and MOSPD2-perturbed cells reveals the homeostatic consequences of losing ER-lipid droplet tethering.

CRISPR knockout of MOSPD2 provides a loss-of-function background to test the requirement for ER-lipid droplet tethering. Re-expression of wild-type versus mutant MOSPD2 can then be used to map the domains required for the activity. This combination of perturbation and rescue is a rigorous way to assign function to GO:0170007.

Biochemical fractionation and proteomic approaches can identify proteins enriched at ER-lipid droplet contact sites. Such methods help determine which proteins co-localize with MOSPD2 and potentially contribute to the tethering activity. These analyses complement imaging by providing a molecular inventory of the contact site.

Researchers studying endoplasmic reticulum-lipid droplet tether activity-related genes often need to determine whether a candidate gene is causally involved in contact site formation and lipid droplet homeostasis, and CRISPR-based cell models provide a rigorous way to establish that causality. EDITGENE supports this work with knockout, point-mutation, knock-in, overexpression, and library screening services tailored to the genes and pathways surrounding GO:0170007.

GO:0170007, endoplasmic reticulum-lipid droplet tether activity, provides a precise molecular_function definition for the binding event that connects lipid droplets to the endoplasmic reticulum and enables exchange and communication between these organelles. MOSPD2 is the best-characterized protein carrying this activity and functions in lipid droplet homeostasis, giving researchers a concrete experimental entry point. By combining CRISPR perturbation with imaging, lipid droplet phenotyping, and lipidomics, it is possible to test how ER-lipid droplet tethering shapes cellular lipid management and disease-relevant phenotypes.